149 related articles for article (PubMed ID: 9098692)
1. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
Van Hooft JA; Vijverberg HP
Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
3. Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors.
van Hooft JA; Kreikamp AP; Vijverberg HP
J Neurochem; 1997 Sep; 69(3):1318-21. PubMed ID: 9282959
[TBL] [Abstract][Full Text] [Related]
4. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors.
Hussy N; Lukas W; Jones KA
J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):311-23. PubMed ID: 7537814
[TBL] [Abstract][Full Text] [Related]
6. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of a rat 5-hydroxytryptamine type3 receptor subunit (r5-HT3A(b)) expressed in Xenopus laevis oocytes.
Mair ID; Lambert JJ; Yang J; Dempster J; Peters JA
Br J Pharmacol; 1998 Aug; 124(8):1667-74. PubMed ID: 9756382
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the apparent splice variants of the murine 5-HT3 R-A subunit expressed in Xenopus laevis oocytes.
Downie DL; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Jones BJ
Neuropharmacology; 1994; 33(3-4):473-82. PubMed ID: 7984286
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital.
Barann M; Göthert M; Bönisch H; Dybek A; Urban BW
Neuropharmacology; 1997; 36(4-5):655-64. PubMed ID: 9225291
[TBL] [Abstract][Full Text] [Related]
10. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
11. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
12. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Sepúlveda MI; Lummis SC; Martin IL
Br J Pharmacol; 1991 Oct; 104(2):536-40. PubMed ID: 1797317
[TBL] [Abstract][Full Text] [Related]
13. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes.
Suzuki T; Koyama H; Sugimoto M; Uchida I; Mashimo T
Anesthesiology; 2002 Mar; 96(3):699-704. PubMed ID: 11873047
[TBL] [Abstract][Full Text] [Related]
14. Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors.
van Hooft JA; Vijverberg HP
Neuropharmacology; 1998; 37(2):259-64. PubMed ID: 9680251
[TBL] [Abstract][Full Text] [Related]
15. Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization.
Delagrange P; Emerit MB; Merahi N; Abraham C; Morain P; Rault S; Renard P; Pfeiffer B; Guardiola-Lemaître B; Hamon M
Eur J Pharmacol; 1996 Dec; 316(2-3):195-203. PubMed ID: 8982686
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.
Lankiewicz S; Lobitz N; Wetzel CH; Rupprecht R; Gisselmann G; Hatt H
Mol Pharmacol; 1998 Feb; 53(2):202-12. PubMed ID: 9463477
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.
Belelli D; Balcarek JM; Hope AG; Peters JA; Lambert JJ; Blackburn TP
Mol Pharmacol; 1995 Dec; 48(6):1054-62. PubMed ID: 8848005
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.
Neijt HC; te Duits IJ; Vijverberg HP
Neuropharmacology; 1988 Mar; 27(3):301-7. PubMed ID: 3374770
[TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist effects of histamine H3 receptor ligands on 5-HT3 receptor-mediated ion currents in NG108-15 cells.
Allen MC
Eur J Pharmacol; 1998 Nov; 361(2-3):261-8. PubMed ID: 9865516
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
